These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 21448162)

  • 1. Autoimmune-like syndromes during TNF blockade: does infection have a role?
    Prinz JC
    Nat Rev Rheumatol; 2011 Mar; 7(7):429-34. PubMed ID: 21448162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Borreliosis mimicking lupus-like syndrome during infliximab treatment.
    Molin S; Ruzicka T; Prinz JC
    Clin Exp Dermatol; 2010 Aug; 35(6):631-3. PubMed ID: 20184613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of TNF/TNFR in autoimmunity: specific TNF receptor blockade may be advantageous to anti-TNF treatments.
    Kollias G; Kontoyiannis D
    Cytokine Growth Factor Rev; 2002; 13(4-5):315-21. PubMed ID: 12220546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic blockade of TNF in patients with SLE-promising or crazy?
    Aringer M; Smolen JS
    Autoimmun Rev; 2012 Mar; 11(5):321-5. PubMed ID: 21619949
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapeutic potential of tumor necrosis factor for autoimmune disease: a mechanistically based hypothesis.
    Kodama S; Davis M; Faustman DL
    Cell Mol Life Sci; 2005 Aug; 62(16):1850-62. PubMed ID: 15968469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential target of infliximab in autoimmune and inflammatory diseases.
    Atzeni F; Doria A; Carrabba M; Turiel M; Sarzi-Puttini P
    Autoimmun Rev; 2007 Sep; 6(8):529-36. PubMed ID: 17854744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoimmune diseases induced by TNF-targeted therapies.
    Ramos-Casals M; Brito-Zerón P; Soto MJ; Cuadrado MJ; Khamashta MA
    Best Pract Res Clin Rheumatol; 2008 Oct; 22(5):847-61. PubMed ID: 19028367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-regulation of TNF and IFN-alpha in autoimmune diseases.
    Palucka AK; Blanck JP; Bennett L; Pascual V; Banchereau J
    Proc Natl Acad Sci U S A; 2005 Mar; 102(9):3372-7. PubMed ID: 15728381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor necrosis factor-alpha antagonists and neuropathy.
    Stübgen JP
    Muscle Nerve; 2008 Mar; 37(3):281-92. PubMed ID: 18041052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TNF alpha antagonist-induced lupus-like syndrome: report and review of the literature with implications for treatment with alternative TNF alpha antagonists.
    Williams VL; Cohen PR
    Int J Dermatol; 2011 May; 50(5):619-25. PubMed ID: 21506984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complement, infection, and autoimmunity.
    Conigliaro P; Triggianese P; Ballanti E; Perricone C; Perricone R; Chimenti MS
    Curr Opin Rheumatol; 2019 Sep; 31(5):532-541. PubMed ID: 31192812
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infection and Malignancy Risk in Patients Treated with TNF Inhibitors for Immune-Mediated Inflammatory Diseases.
    Pereira R; Faria R; Lago P; Torres T
    Curr Drug Saf; 2017; 12(3):162-170. PubMed ID: 28625143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases.
    Ramos-Casals M; Brito-Zerón P; Muñoz S; Soria N; Galiana D; Bertolaccini L; Cuadrado MJ; Khamashta MA
    Medicine (Baltimore); 2007 Jul; 86(4):242-251. PubMed ID: 17632266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TNF blocker drugs modulate human TNF-α-converting enzyme pro-domain shedding induced by autoantibodies.
    Sisto M; Lisi S; Lofrumento DD; Caprio S; Mitolo V; D'Amore M
    Immunobiology; 2010 Nov; 215(11):874-83. PubMed ID: 20061048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tumor necrosis factor therapy abrogates autoimmune demyelination.
    Selmaj K; Raine CS; Cross AH
    Ann Neurol; 1991 Nov; 30(5):694-700. PubMed ID: 1722388
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atherosclerosis and autoimmunity: a growing relationship.
    Sanjadi M; Rezvanie Sichanie Z; Totonchi H; Karami J; Rezaei R; Aslani S
    Int J Rheum Dis; 2018 May; 21(5):908-921. PubMed ID: 29671956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The critical role of epigenetics in systemic lupus erythematosus and autoimmunity.
    Long H; Yin H; Wang L; Gershwin ME; Lu Q
    J Autoimmun; 2016 Nov; 74():118-138. PubMed ID: 27396525
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics.
    Jang DI; Lee AH; Shin HY; Song HR; Park JH; Kang TB; Lee SR; Yang SH
    Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of TWEAK/Fn14 in the pathogenesis of inflammation and systemic autoimmunity.
    Campbell S; Michaelson J; Burkly L; Putterman C
    Front Biosci; 2004 Sep; 9():2273-84. PubMed ID: 15353286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-TNF-alpha antibody therapies in autoimmune diseases.
    Chatzantoni K; Mouzaki A
    Curr Top Med Chem; 2006; 6(16):1707-14. PubMed ID: 17017952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.